Panos ANTSAKLIS | Obstetrics & Gynecology | Research profile
SCIENTIFIC WORKS
PDF) The Hamster Model of Sequential Oral Carcinogenesis: An Update
PDF) Molecular Characterization of a Long-Term Survivor Double Metastatic Non-Small Cell Lung Cancer and Pancreatic Ductal Adenocarcinoma Treated with Gefitinib in Combination with Gemcitabine Plus Nab-Paclitaxel and mFOLFOX6 as First and Second
Panos ANTSAKLIS | Obstetrics & Gynecology | Research profile
Cancers | Free Full-Text | Molecular Characterization of a Long-Term Survivor Double Metastatic Non-Small Cell Lung Cancer and Pancreatic Ductal Adenocarcinoma Treated with Gefitinib in Combination with Gemcitabine Plus Nab-Paclitaxel and mFOLFOX6
PDF) FGFR-2 and -3 Play an Important Role in Initial Stages of Oral Oncogenesis
PDF) Molecular Characterization of a Long Term Survivor Double Metastatic Non Small Sell Lung Cancer and Pancreatic Ductal Adenocarcinoma Treated with Gefitinib in Combination with Gemcitabine Plus Nab-Paclitaxel and mFOLFOX6 as First
SCIENTIFIC WORKS
SCIENTIFIC WORKS
PDF) Review of Disease-Specific microRNAs by Strategically Bridging Genetics and Epigenetics in Oral Squamous Cell Carcinoma
Panos ANTSAKLIS | Obstetrics & Gynecology | Research profile
SCIENTIFIC WORKS
Cancers | Free Full-Text | Molecular Characterization of a Long-Term Survivor Double Metastatic Non-Small Cell Lung Cancer and Pancreatic Ductal Adenocarcinoma Treated with Gefitinib in Combination with Gemcitabine Plus Nab-Paclitaxel and mFOLFOX6
PDF) The Hamster Model of Sequential Oral Carcinogenesis: An Update
The Hamster Model of Sequential Oral Carcinogenesis: An Update | In Vivo
PDF) Review of Disease-Specific microRNAs by Strategically Bridging Genetics and Epigenetics in Oral Squamous Cell Carcinoma
Panos ANTSAKLIS | Obstetrics & Gynecology | Research profile
PDF) Molecular Characterization of a Long-Term Survivor Double Metastatic Non-Small Cell Lung Cancer and Pancreatic Ductal Adenocarcinoma Treated with Gefitinib in Combination with Gemcitabine Plus Nab-Paclitaxel and mFOLFOX6 as First and Second
PDF) Histone Deacetylase Inhibitors as a Novel Targeted Therapy Against Non-small Cell Lung Cancer: Where Are We Now and What Should We Expect?
Histone Deacetylase Inhibitors as a Novel Targeted Therapy Against Non-small Cell Lung Cancer: Where Are We Now and What Should We Expect? | Anticancer Research
Ers 2015 | PDF | Pulmonology | Cytopathology
PDF) Histone Deacetylase Inhibitors as a Novel Targeted Therapy Against Non-small Cell Lung Cancer: Where Are We Now and What Should We Expect?
Panos ANTSAKLIS | Obstetrics & Gynecology | Research profile
SCIENTIFIC WORKS
A Next-Generation Sequencing approach for the study of hereditary tumors
Panos ANTSAKLIS | Obstetrics & Gynecology | Research profile
Panos ANTSAKLIS | Obstetrics & Gynecology | Research profile
